Feasibility and Safety of CareMin650 in Patients at Risk of or Suffering From Oral Mucositis and/or Radiation Dermatitis

NCT03988556 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Mucositis Due to Radiation
Radiation Dermatitis

Interventions

DEVICE: Photobiomodulation using CareMin650 at 6 Joules (curative intent)
DEVICE: Photobiomodulation using CareMin650 at 3 Joules (prophylactic intent)

Sponsor

NeoMedLight

Collaborators

[object Object]